Notice of Extension of the Expiration Date of PAR-22-000, "Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)"
Notice Number:
NOT-EB-24-008

Key Dates

Release Date:

April 16, 2024

Related Announcements

  • February 23, 2022 - Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed). See  PAR-22-000

Issued by

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

The purpose of this Notice is to extend the expiration date of PAR-22-000, "Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)” by one application due date.

The following section of PAR-22-000 has been modified to reflect the changes:

Part 1. Overview

Key Dates

Currently reads:

Expiration Date   May 31, 2024

Modified to read (changes shown in bold italics):

Expiration Date   January 30, 2025

Application Due Dates

Review and Award Cycles

NewRenewal / Resubmission / Revision (as allowed)AIDSScientific Merit ReviewAdvisory Council ReviewEarliest Start Date
May 30, 2022May 30, 2022Not ApplicableNovember 2022January 2023April 2023
May 30, 2023May 30, 2023Not ApplicableNovember 2023January 2024April 2024
May 30, 2024May 30, 2024Not ApplicableNovember 2024January 2025April 2025
 January 29, 2025 January 29, 2025Not applicableJuly 2025October 2025December 2025

All other aspects of PAR-22-000 remain the same. 

Inquiries

Please direct all inquiries to:

Dave Gutekunst, Ph.D.
National Institute Of Biomedical Imaging And Bioengineering (NIBIB)
Telephone: 240-789-0004
E-mail: dave.gutekunst@nih.gov